Metabolomics Approach in Allergic and Rheumatic Diseases

Metabolomics is the analysis of the concentration profiles of low molecular weight compounds present in biological fluids. Metabolites are nonpeptide molecules representing the end products of cellular activity. Therefore, changes in metabolite concentrations reveal the range of biochemical effects induced by a disease or its therapeutic intervention. Metabolomics has recently become feasible with the accessibility of new technologies, including mass spectrometry and high-resolution proton nuclear magnetic resonance, and has already been applied to several disorders. Indeed, it has the advantage of being a nontargeted approach for identifying potential biomarkers, which means that it does not require a preliminary knowledge of the substances to be studied. In this review, we summarize the main studies in which metabolomic approach was used in some allergic (asthma, atopic dermatitis) and rheumatic diseases (rheumatoid arthritis, systemic lupus erythematosus) to explore the feasibility of this technique as a novel diagnostic tool in these complex disorders.

[1]  P. J. Barnes,et al.  Exhaled breath condensate: methodological recommendations and unresolved questions , 2005, European Respiratory Journal.

[2]  Douglas B. Kell,et al.  Proposed minimum reporting standards for data analysis in metabolomics , 2007, Metabolomics.

[3]  T. Lundstedt,et al.  Diagnostic properties of metabolic perturbations in rheumatoid arthritis , 2011, Arthritis Research & Therapy.

[4]  M. Valerio,et al.  Metabolomics in rheumatic diseases: the potential of an emerging methodology for improved patient diagnosis, prognosis, and treatment efficacy. , 2013, Autoimmunity reviews.

[5]  A. Boner,et al.  An exploratory 1H‐nuclear magnetic resonance metabolomics study reveals altered urine spectral profiles in infants with atopic dermatitis , 2012, The British journal of dermatology.

[6]  P. Sarzi-Puttini,et al.  Predicting response to anti-TNF treatment in rheumatoid arthritis patients. , 2009, Autoimmunity reviews.

[7]  A. Barton,et al.  Biomarkers and personalised medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodies , 2011, Annals of the rheumatic diseases.

[8]  J. Lindon,et al.  Metabonomics: a platform for studying drug toxicity and gene function , 2002, Nature Reviews Drug Discovery.

[9]  J. Griffin.  Metabolic profiles to define the genome: can we hear the phenotypes? , 2004, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[10]  B. Shushan.  A review of clinical diagnostic applications of liquid chromatography-tandem mass spectrometry. , 2010, Mass spectrometry reviews.

[11]  S. Rantapää-Dahlqvist,et al.  Lipoprotein (a), lipids, and lipoproteins in patients with rheumatoid arthritis. , 1991, Annals of the rheumatic diseases.

[12]  H. Peh,et al.  Metabolomics reveals altered metabolic pathways in experimental asthma. , 2013, American journal of respiratory cell and molecular biology.

[13]  Károly Héberger,et al.  Metabolomics applied to exhaled breath condensate in childhood asthma. , 2007, American journal of respiratory and critical care medicine.

[14]  B. Hammock,et al.  Mass spectrometry-based metabolomics. , 2007, Mass spectrometry reviews.

[15]  A. Custovic,et al.  Breath metabolomic profiling by nuclear magnetic resonance spectroscopy in asthma , 2013, Allergy.

[16]  Michael A Kennedy,et al.  Identification of urinary metabolites that distinguish membranous lupus nephritis from proliferative lupus nephritis and focal segmental glomerulosclerosis , 2011, Arthritis research & therapy.

[17]  O. Fiehn.  Metabolomics – the link between genotypes and phenotypes , 2004, Plant Molecular Biology.

[18]  F. Reniero,et al.  Asthma severity in childhood and metabolomic profiling of breath condensate , 2013, Allergy.

[19]  Zhe Chen,et al.  (1)H NMR-based metabolomic analysis for identifying serum biomarkers to evaluate methotrexate treatment in patients with early rheumatoid arthritis. , 2012, Experimental and therapeutic medicine.

[20]  V. Valderrábano,et al.  Synovial fluid metabolomics in different forms of arthritis assessed by nuclear magnetic resonance spectroscopy. , 2012, Clinical and experimental rheumatology.

[21]  I. Pavord,et al.  Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial , 2002, The Lancet.

[22]  B. Canning.  Modeling asthma and COPD in animals: a pointless exercise? , 2003, Current opinion in pharmacology.

[23]  Frederick Wolfe,et al.  Rheumatoid arthritis , 2010, The Lancet.

[24]  Hans Bisgaard,et al.  Prevalence of asthma‐like symptoms in young children , 2007, Pediatric pulmonology.

[25]  E Holmes,et al.  Chemometric contributions to the evolution of metabonomics: mathematical solutions to characterising and interpreting complex biological NMR spectra. , 2002, The Analyst.

[26]  P. Howarth,et al.  Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. , 1992, The American review of respiratory disease.

[27]  Erik J. Saude,et al.  Metabolomic biomarkers in a model of asthma exacerbation: urine nuclear magnetic resonance. , 2009, American journal of respiratory and critical care medicine.

[28]  I. Pavord,et al.  Biomarkers Predicting Response to Corticosteroid Therapy in Asthma , 2005, Treatments in respiratory medicine.

[29]  M. Fitzpatrick,et al.  Metabolic Profiling Predicts Response to Anti–Tumor Necrosis Factor α Therapy in Patients With Rheumatoid Arthritis , 2013, Arthritis and rheumatism.

[30]  M. Viant,et al.  The Impact of Inflammation on Metabolomic Profiles in Patients With Arthritis , 2013, Arthritis and rheumatism.

[31]  L. Hood,et al.  A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory. , 2012, New biotechnology.

[32]  L. Yao,et al.  Rapid Resolution Liquid Chromatography Coupled with Quadrupole Time-of-Flight Mass Spectrometry-Based Metabolomics Approach to Study the Effects of Jieduquyuziyin Prescription on Systemic Lupus Erythematosus , 2014, PloS one.

[33]  Thomas Bieber,et al.  Atopic dermatitis. , 2008, The New England journal of medicine.

[34]  Ara W. Darzi,et al.  Metabolic phenotyping in clinical and surgical environments , 2012, Nature.

[35]  A. Laptook,et al.  Effects of Lactic Acid Infusions and pH on Cerebral Blood Flow and Metabolism , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[36]  Zhe Chen,et al.  1H NMR-based metabolomic analysis for identifying serum biomarkers to evaluate methotrexate treatment in patients with early rheumatoid arthritis , 2012 .

[37]  T. Bieber.  Atopic dermatitis 2.0: from the clinical phenotype to the molecular taxonomy and stratified medicine , 2012, Allergy.

[38]  J. Meulman,et al.  Characterization of Rheumatoid Arthritis Subtypes Using Symptom Profiles, Clinical Chemistry and Metabolomics Measurements , 2012, PloS one.

[39]  T. Bieber,et al.  Atopic dermatitis: a candidate for disease‐modifying strategy , 2012, Allergy.

[40]  J. Hanifin.  Evolving concepts of pathogenesis in atopic dermatitis and other eczemas. , 2009, The Journal of investigative dermatology.

[41]  Lx Wang,et al.  1H NMR-based metabolomic study of metabolic profiling for systemic lupus erythematosus , 2011, Lupus.

[42]  K. Takabayashi,et al.  Decreased Regional Cerebral Metabolic Rate for Glucose in Systemic Lupus erythematosus Patients with Psychiatric Symptoms , 1999, European Neurology.

[43]  C. Guillou,et al.  Metabolomics applied to urine samples in childhood asthma; differentiation between asthma phenotypes and identification of relevant metabolites. , 2012, Biomedical chromatography : BMC.

[44]  G. Hwang,et al.  Serum metabolomics reveals pathways and biomarkers associated with asthma pathogenesis , 2013, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[45]  J. Griffin.  The Cinderella story of metabolic profiling: does metabolomics get to go to the functional genomics ball? , 2006, Philosophical Transactions of the Royal Society B: Biological Sciences.

[46]  Hongwei Kong,et al.  Plasma metabonomics study of rheumatoid arthritis and its Chinese medicine subtypes by using liquid chromatography and gas chromatography coupled with mass spectrometry. , 2012, Molecular bioSystems.

[47]  Cheng Xiao,et al.  Correlation between cold and hot pattern in traditional Chinese medicine and gene expression profiles in rheumatoid arthritis , 2011, Frontiers of medicine.

[48]  R. Bennett,et al.  1H NMR spectroscopy-based interventional metabolic phenotyping: a cohort study of rheumatoid arthritis patients. , 2010, Journal of proteome research.

[49]  N. Gibbs,et al.  Recent advances in urocanic acid photochemistry, photobiology and photoimmunology , 2008, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[50]  Johan Trygg,et al.  Chemometrics in metabonomics. , 2007, Journal of proteome research.

[51]  H. Zeidler.  The Need to Better Classify and Diagnose Early and Very Early Rheumatoid Arthritis , 2012, The Journal of Rheumatology.

[52]  M. Giera,et al.  Lipid and lipid mediator profiling of human synovial fluid in rheumatoid arthritis patients by means of LC-MS/MS. , 2012, Biochimica et biophysica acta.

[53]  C. Zwingmann,et al.  MRL/lpr mice have alterations in brain metabolism as shown with [1H–13C] NMR spectroscopy , 2005, Neurochemistry International.

[54]  J. Schoones,et al.  What is the evidence for the presence of a therapeutic window of opportunity in rheumatoid arthritis? A systematic literature review , 2013, Annals of the rheumatic diseases.

[55]  H. Vogel,et al.  An inflammatory arthritis-associated metabolite biomarker pattern revealed by 1H NMR spectroscopy. , 2007, Journal of proteome research.

[56]  Erik J. Saude,et al.  Metabolomic profiling of asthma: diagnostic utility of urine nuclear magnetic resonance spectroscopy. , 2011, The Journal of allergy and clinical immunology.

[57]  Chandra Mohan,et al.  Metabolic Disturbances Associated with Systemic Lupus Erythematosus , 2012, PloS one.

[58]  J. Kreidberg,et al.  Development of the renal glomerulus: good neighbors and good fences , 2008, Development.

[59]  A. Fryer,et al.  Pretreatment with antibody to eosinophil major basic protein prevents hyperresponsiveness by protecting neuronal M2 muscarinic receptors in antigen-challenged guinea pigs. , 1997, The Journal of clinical investigation.

[60]  D. Fabian,et al.  The global burden of asthma: executive summary of the GINA Dissemination Committee Report , 2004, Allergy.

[61]  H. Hagino,et al.  Nuclear magnetic resonance studies of synovial fluids from patients with rheumatoid arthritis and osteoarthritis. , 1999, Clinica chimica acta; international journal of clinical chemistry.